Regulation of p53 stability by Mdm2

作者: Michael H. G. Kubbutat , Stephen N. Jones , Karen H. Vousden

DOI: 10.1038/387299A0

关键词:

摘要: The tumour-suppressor p53 is a short-lived protein that maintained at low, often undetectable, levels in normal cells. Stabilization of the response to an activating signal, such as DNA damage, results rapid rise and subsequent inhibition cell growth. Tight regulation function critical for growth development, one mechanism by which controlled through interaction with Mdm2 protein. inhibits cell-cycle arrest apoptic functions we show here can also result large reduction enhanced proteasome-dependent degradation. Endogenous are sufficient regulate stability, overexpression reduce amount endogenous p53. Because mdm2 transcriptionally activated p53, this degradative pathway may contribute maintenance low concentrations Furthermore, mechanisms regulating Mdm2-induced degradation play role controlling extent duration response.

参考文章(30)
Y. Haupt, Y. Barak, M. Oren, Cell type-specific inhibition of p53-mediated apoptosis by mdm2. The EMBO Journal. ,vol. 15, pp. 1596- 1606 ,(1996) , 10.1002/J.1460-2075.1996.TB00504.X
S. Rowan, R. L. Ludwig, Y. Haupt, S. Bates, X. Lu, M. Oren, K. H. Vousden, Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. The EMBO Journal. ,vol. 15, pp. 827- 838 ,(1996) , 10.1002/J.1460-2075.1996.TB00418.X
Y. Barak, T. Juven, R. Haffner, M. Oren, mdm2 expression is induced by wild type p53 activity. The EMBO Journal. ,vol. 12, pp. 461- 468 ,(1993) , 10.1002/J.1460-2075.1993.TB05678.X
J Chen, V Marechal, A J Levine, Mapping of the p53 and mdm-2 interaction domains. Molecular and Cellular Biology. ,vol. 13, pp. 4107- 4114 ,(1993) , 10.1128/MCB.13.7.4107
Peter M. Howley, Carl G. Maki, Jon M. Huibregtse, In Vivo Ubiquitination and Proteasome-mediated Degradation of p53 Cancer Research. ,vol. 56, pp. 2649- 2654 ,(1996)
Jonathan D. Oliner, Jennifer A. Pietenpol, Sam Thiagalingam, Jeno Gyuris, Kenneth W. Kinzler, Bert Vogelstein, Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Nature. ,vol. 362, pp. 857- 860 ,(1993) , 10.1038/362857A0
David Wrede, John A. Tidy, Tim Crook, David Lane, Karen H. Vousden, Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Molecular Carcinogenesis. ,vol. 4, pp. 171- 175 ,(1991) , 10.1002/MC.2940040302
Roberta Montes de Oca Luna, Daniel S. Wagner, Guillermina Lozano, Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 Nature. ,vol. 378, pp. 203- 206 ,(1995) , 10.1038/378203A0
Stewart Bates, Karen H. Vousden, p53 in signaling checkpoint arrest or apoptosis Current Opinion in Genetics & Development. ,vol. 6, pp. 12- 18 ,(1996) , 10.1016/S0959-437X(96)90004-0